RankingsPricing
  1. US-listed companies
  2. MoonLake Immunotherapeutics

MoonLake ImmunotherapeuticsMLTX

Market cap
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023
Net loss---64,506,051-44,079,117
Depreciation--12,35813,158
Share-based compensation expense--107
Pension Expense (Reversal of Expense), Noncash--304,031-85,254
Pension Expense (Reversal of Expense), Noncash--304,031-85,254
Other non-cash items---68,454-484,762
Other non-cash items---68,454-484,762
Other receivables--68,355839,733
Prepaid expenses283,057-156,14136
Right-of-use assets---65,513
Trade and other payables---1,314,3182
Prepaid expenses283,057-156,14136
Accrued expenses and other current liabilities--3-326,725
Trade and other payables---1,314,3182
Operating leases liabilities----222,259
Accrued expenses and other current liabilities--3-326,725
Other receivables--68,355839,733
Prepaid expenses283,057-156,14136
Right-of-use assets---65,513
Trade and other payables---1,314,3182
Prepaid expenses283,057-156,14136
Accrued expenses and other current liabilities--3-326,725
Trade and other payables---1,314,3182
Operating leases liabilities----222,259
Accrued expenses and other current liabilities--3-326,725
Net cash flow used in operating activities-316,692-611,071-55,893,900-42,778,167
Purchase of short-term marketable debt securities--42176
Proceeds from maturities of short-term marketable debt securities--10151
Purchase of property and equipment--16,009284,634
Net cash flow used in investing activities-115,000,000--32,340,593-25,184,324
Proceeds from Issuance Initial Public Offering---482
Stamp duty on capital injection from MoonLake to MoonLake AG (Note 12)---3
Proceeds from Business Combination--135-
Contribution for par value of Class V Shares--42,935-
Repayment of loan liability--15-
Repayment of loan liability--15-
Grants of additional shares under ESPP--3,791-
Net cash flow provided by financing activities117-58,063120480
Grants of additional shares under ESPP--3,791-
Net cash flow provided by financing activities117-58,063120480
Effect of movements in exchange rates on cash held--8,540-75,307
Net change in cash and cash equivalents--31412
Income Taxes Paid, Net--4,31241,713
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability--435,0054
Operating Lease, Payments---422,519